Publication Author: Sullivan_Sean

• Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.

  Sullivan SD, Kwong L, Nutescu E. Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery. Value Health. 2006 Mar-Apr;9(2):68-76.

  rakerr2

  March 1, 2006

• Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease.

  van der Palen J, Monninkhof E, van der Valk P, Sullivan SD, Veenstra DL. Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease. Thorax. 2006 Jan;61(1):29-33. Epub 2005 Oct 21.

  rakerr2

  January 1, 2006

• Economic evaluation in the US: what is the missing link?

  Neumann PJ, Sullivan SD. Economic evaluation in the US: what is the missing link? Pharmacoeconomics. 2006;24(11):1163-8. Review.

  rakerr2

  January 1, 2006

• Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team.

  Finkelstein JA, Lozano P, Fuhlbrigge AL, Carey VJ, Inui TS, Soumerai SB, Sullivan SD, Wagner EH, Weiss ST, Weiss KB; Pediatric Asthma Care Patient Outcomes Research Team. Practice-level effects of interventions to improve asthma care in primary care setti

  rakerr2

  December 1, 2005

• Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply.

  Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Murphy EL, Busch MP. Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making. 2005 Sep-Oct;25(5):571-82.

  rakerr2

  September 1, 2005

• The burden of uncontrolled asthma on the U.S. health care system.

  Sullivan SD. The burden of uncontrolled asthma on the U.S. health care system. Manag Care. 2005 Aug;14(8 Suppl):4-7; discussion 25-7.

  rakerr2

  August 1, 2005

• Response to Wolf [corrected] and Marks.

  Fuhlbrigge A, Sullivan SD. Response to Wolf [corrected] and Marks. J Allergy Clin Immunol. 2005 Jul;116(1):230-1. Erratum in: J Allergy Clin Immunol. 2005 Oct;116(4):936.

  rakerr2

  July 1, 2005

• States’ control of prescription drug spending: a heterogeneous approach.

  Morden NE, Sullivan SD. States’ control of prescription drug spending: a heterogeneous approach. Health Aff (Millwood). 2005 Jul-Aug;24(4):1032-8.

  rakerr2

  July 1, 2005

• Global management guidelines and quality of care indicators for asthma and COPD.

  Sullivan SD. Global management guidelines and quality of care indicators for asthma and COPD. Manag Care. 2005 Jul;14(7 Suppl Obstructie Lung):16-9; discussion 24-6.

  rakerr2

  July 1, 2005

• Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale.

  Au DH, Blough DK, Kirchdoerfer L, Weiss KB, Udris EM, Sullivan SD. Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale. COPD. 2005 Jun;2(2):209-16.

  rakerr2

  June 1, 2005